Intra-individual Pharmacokinetic Variability of Intravenous Busulfan in Hematopoietic Stem Cell-Transplanted Children
ConclusionsSignificant busulfan intra-individual variability may occur in children who receive a HSCT and is hardly predictable. The main risk is busulfan overexposure. Performing TDM repeatedly over therapy appears to be the best way to accurately estimate busulfan exposure and perform precision dosing.
Source: Clinical Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
More News: Children | Drugs & Pharmacology | Learning | Stem Cell Therapy | Stem Cells | Study | Transplants | Universities & Medical Training